NYSE$USPH

US Physical Therapy Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Reported decrease in net revenues due to the adverse effects of the COVID-19 pandemic.

U.S. Physical Therapy reported a decrease in net revenues for the second quarter of 2020 compared to the same period in 2019, primarily due to the adverse effects of the COVID-19 pandemic. However, the company's physical therapy daily patient volumes improved throughout the quarter, and the industrial injury prevention business remained relatively stable.

  • Net revenues for the second quarter of 2020 were $83.9 million, compared to $126.4 million in the second quarter of 2019.
  • Net patient revenues from physical therapy operations were approximately $72.3 million in the second quarter of 2020 and $113.4 million in the second quarter of 2019.
  • Revenue from the industrial injury prevention business was $9.7 million in the second quarter of 2020, compared to $10.3 million in the second quarter of 2019.
  • Operating income for the second quarter of 2020 was $10.3 million, compared to $19.9 million for the second quarter of 2019.

Headline financials

Total Revenue

$83.9M

Previous: $126M-33.6%
EPS (adj)

$0.85

Previous: $0.81+4.9%
Total Patient Visits

675.7K

Previous: 1.1M-36.1%
Free Cash Flow

$10.2M

Previous: $14.6M-30.0%
Net Income

$10.2M

Previous: $14.6M-30.0%
Operating Income

$10.3M

Previous: $19.9M-48.4%
Gross Profit

$19.3M

Previous: $31.4M-38.6%
Cash & Equivalents

$43.6M

Previous: $34.9M+24.9%
Total Assets

$585M

Previous: $557M+5.0%
Stock-Based Comp

$1.5M

No prior period

Revenue & EPS history

US Physical Therapy · Revenue · Quarterly

$83.9M

Q2 2020-33.6%vs Q2 2019
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

US Physical Therapy · $9.7M total across 1 segment · Q2 2020

  • Injury Prevention
    $9.7M

Forward guidance

This press release contains forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those expected.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-1.3%

Avg return

30 days after

53%

35 / 66 earnings

Positive

+17.3%

Q3 2024

Best reaction

-27.5%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+1.3%+7.5%
Q4 2025-2.9%+1.9%-8.5%
Q3 2025+0.9%-15.8%-13.8%
Q2 2025+14.7%+20.4%+17.8%
Q1 2025-0.1%+8.8%+8.9%
Q4 2024-6.0%-9.5%-18.0%
Q3 2024+17.3%+14.8%+17.9%
Q2 2024-6.8%-3.9%-5.4%
Q1 2024-2.2%+0.2%-8.0%
Q4 2023+3.4%+2.8%+9.8%
Q3 2023-2.8%-3.3%+4.3%
Q2 2023-8.6%-8.1%-19.8%
Q1 2023+4.5%+10.1%+2.1%
Q4 2022+2.1%+2.2%-5.7%
Q3 2022-8.9%-4.0%-0.3%
Q2 2022-27.5%-29.9%-37.0%
Q1 2022-4.4%-4.1%+4.2%
Q4 2021-5.8%-6.5%-2.1%
Q3 2021-3.6%-8.2%-21.6%
Q2 2021-3.6%-5.4%-1.1%
Q1 2021+6.0%+4.5%+6.6%
Q4 2020-17.2%-19.8%-24.3%
Q3 2020+8.4%+26.6%+29.2%
Q2 2020+2.4%+1.1%+3.7%
Q1 2020-1.0%+2.7%+0.9%
Q4 2019-17.7%-16.0%-49.0%
Q3 2019-20.1%-20.4%-20.5%
Q2 2019+3.9%+6.1%+8.1%
Q1 2019+2.3%+3.3%-1.2%
Q4 2018+3.2%+3.4%+2.1%
Q3 2018+5.1%+6.5%+10.7%
Q2 2018+8.9%+7.0%+18.9%
Q1 2018-1.4%-0.5%+2.4%
Q4 2017+6.8%+2.7%+4.9%
Q3 2017-2.6%-2.9%+5.7%
Q2 2017+2.4%+2.6%-2.9%
Q1 2017-6.0%+0.8%-2.1%
Q4 2016+1.7%+2.0%-1.2%
Q3 2016-1.2%+0.5%+14.3%
Q2 2016+4.7%+4.0%+9.7%
Q1 2016+12.7%
Q4 2015+1.2%
Q3 2015+2.3%
Q2 2015-5.0%
Q1 2015+7.9%
Q4 2014+5.4%
Q3 2014-7.2%
Q2 2014+5.8%
Q1 2014+3.0%
Q4 2013-0.3%
Q3 2013-7.1%
Q2 2013+6.0%
Q1 2013+3.5%
Q4 2012-4.6%
Q3 2012+0.6%
Q2 2012+0.6%
Q1 2011+1.0%
Q1 2012+2.1%
Q4 2009-0.2%
Q4 2011-0.2%
Q3 2011+1.9%
Q3 2010+1.9%
Q2 2010-10.9%
Q2 2011-10.9%
Q4 2010-10.9%
Q1 2010+12.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro